{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:16:56Z","timestamp":1762867016179},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T00:00:00Z","timestamp":1482969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s10620-016-4431-8","type":"journal-article","created":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T11:50:08Z","timestamp":1483012208000},"page":"808-816","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis"],"prefix":"10.1007","volume":"62","author":[{"given":"Eui Joo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Eun","family":"Yeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oh Sang","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heon Nam","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Kak","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Hee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwan Soo","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So Young","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Jun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Joon","family":"Yim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,29]]},"reference":[{"key":"4431_CR1","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","volume":"127","author":"FX Bosch","year":"2004","unstructured":"Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:S5\u2013S16.","journal-title":"Gastroenterology"},{"key":"4431_CR2","unstructured":"The Korean Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2011. Ministry of Health and Welfare. 2013."},{"key":"4431_CR3","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557\u20132576.","journal-title":"Gastroenterology"},{"key":"4431_CR4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"CJ Chen","year":"2006","unstructured":"Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65\u201373.","journal-title":"JAMA"},{"key":"4431_CR5","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jnci\/djn243","volume":"100","author":"HI Yang","year":"2008","unstructured":"Yang HI, Yeh SH, Chen PJ, et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst. 2008;100:1134\u20131143.","journal-title":"J Natl Cancer Inst"},{"key":"4431_CR6","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1053\/j.gastro.2011.06.036","volume":"141","author":"CF Chen","year":"2011","unstructured":"Chen CF, Lee WC, Yang HI, et al. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma. Gastroenterology. 2011;141:1240\u20131248. 1248 e1241\u20131242.","journal-title":"Gastroenterology"},{"key":"4431_CR7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.hepres.2005.02.006","volume":"32","author":"A Matsumoto","year":"2005","unstructured":"Matsumoto A, Tanaka E, Rokuhara A, et al. Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: a multicenter retrospective study of 2795 patients. Hepatol Res. 2005;32:173\u2013184.","journal-title":"Hepatol Res"},{"key":"4431_CR8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00535-011-0522-7","volume":"47","author":"M Kurokawa","year":"2012","unstructured":"Kurokawa M, Hiramatsu N, Oze T, et al. Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection. J Gastroenterol. 2012;47:577\u2013585.","journal-title":"J Gastroenterol"},{"key":"4431_CR9","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","volume":"351","author":"YF Liaw","year":"2004","unstructured":"Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351:1521\u20131531.","journal-title":"N Engl J Med"},{"key":"4431_CR10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/gast.2003.50013","volume":"124","author":"JL Dienstag","year":"2003","unstructured":"Dienstag JL, Goldin RD, Heathcote EJ, et al. Histological outcome during long-term lamivudine therapy. Gastroenterology. 2003;124:105\u2013117.","journal-title":"Gastroenterology"},{"key":"4431_CR11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.23327","volume":"51","author":"TT Chang","year":"2010","unstructured":"Chang TT, Lai CL, Kew Yoon S, et al. Entecavir treatment for up to 5\u00a0years in patients with hepatitis B e antigen-positive chronic hepatitis B. Hepatology. 2010;51:422\u2013430.","journal-title":"Hepatology"},{"key":"4431_CR12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.26180","volume":"58","author":"T Hosaka","year":"2013","unstructured":"Hosaka T, Suzuki F, Kobayashi M, et al. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology. 2013;58:98\u2013107.","journal-title":"Hepatology"},{"key":"4431_CR13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.gastro.2014.02.033","volume":"147","author":"YS Lim","year":"2014","unstructured":"Lim YS, Han S, Heo NY, Shim JH, Lee HC, Suh DJ. Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine. Gastroenterology. 2014;147:152\u2013161.","journal-title":"Gastroenterology"},{"key":"4431_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/kjhep.2012.18.1.1","volume":"18","author":"KT Suk","year":"2012","unstructured":"Suk KT, Baik SK, Yoon JH, et al. Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol. 2012;18:1\u201321.","journal-title":"Korean J Hepatol"},{"key":"4431_CR15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3350\/kjhep.2009.15.3.391","volume":"15","author":"Korean Liver Cancer Study G, National Cancer Center K","year":"2009","unstructured":"Korean Liver Cancer Study G, National Cancer Center K. Practice guidelines for management of hepatocellular carcinoma. Korean J Hepatol. 2009;15:391\u2013423.","journal-title":"Korean J Hepatol"},{"key":"4431_CR16","unstructured":"World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. 2000."},{"key":"4431_CR17","first-page":"2013","volume-title":"Korea National Health and Nutrition Examination Survey (KNHANES V-3)","author":"Ministry of Health and Welfare; Korea Centers for Disease Control and Prevention. Korea health statistics","year":"2012","unstructured":"Ministry of Health and Welfare; Korea Centers for Disease Control and Prevention. Korea health statistics. Korea National Health and Nutrition Examination Survey (KNHANES V-3). Seoul: Ministry of Health and Welfare; 2012:2013."},{"key":"4431_CR18","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1111\/j.1440-1746.1997.tb00513.x","volume":"12","author":"CJ Chen","year":"1997","unstructured":"Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol. 1997;12:S294\u2013S308.","journal-title":"J Gastroenterol Hepatol"},{"key":"4431_CR19","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/1097-0142(19941015)74:8<2234::AID-CNCR2820740805>3.0.CO;2-6","volume":"74","author":"Y Kato","year":"1994","unstructured":"Kato Y, Nakata K, Omagari K, et al. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer. 1994;74:2234\u20132238.","journal-title":"Cancer"},{"key":"4431_CR20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/infdis\/146.2.205","volume":"146","author":"KJ Lo","year":"1982","unstructured":"Lo KJ, Tong MJ, Chien MC, et al. The natural course of hepatitis B surface antigen-positive chronic active hepatitis in Taiwan. J Infect Dis. 1982;146:205\u2013210.","journal-title":"J Infect Dis"},{"key":"4431_CR21","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","volume":"127","author":"G Fattovich","year":"2004","unstructured":"Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127:S35\u2013S50.","journal-title":"Gastroenterology"},{"key":"4431_CR22","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/clinchem\/21.8.1077","volume":"21","author":"G Siest","year":"1975","unstructured":"Siest G, Schiele F, Galteau MM, et al. Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin Chem. 1975;21:1077\u20131087.","journal-title":"Clin Chem"},{"key":"4431_CR23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(92)92234-7","volume":"340","author":"A Alberti","year":"1992","unstructured":"Alberti A, Morsica G, Chemello L, et al. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet. 1992;340:697\u2013698.","journal-title":"Lancet"},{"key":"4431_CR24","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1111\/j.1572-0241.1999.01451.x","volume":"94","author":"S Daniel","year":"1999","unstructured":"Daniel S, Ben-Menachem T, Vasudevan G, Ma CK, Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol. 1999;94:3010\u20133014.","journal-title":"Am J Gastroenterol"},{"key":"4431_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","volume":"137","author":"D Prati","year":"2002","unstructured":"Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137:1\u201310.","journal-title":"Ann Intern Med"},{"key":"4431_CR26","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.23505","volume":"51","author":"JK Lee","year":"2010","unstructured":"Lee JK, Shim JH, Lee HC, et al. Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology. Hepatology. 2010;51:1577\u20131583.","journal-title":"Hepatology"},{"key":"4431_CR27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1440-1746.2012.07143.x","volume":"28","author":"W Sohn","year":"2013","unstructured":"Sohn W, Jun DW, Kwak MJ, et al. Upper limit of normal serum alanine and aspartate aminotransferase levels in Korea. J Gastroenterol Hepatol. 2013;28:522\u2013529.","journal-title":"J Gastroenterol Hepatol"},{"key":"4431_CR28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1440-1746.2010.06481.x","volume":"26","author":"HS Kang","year":"2011","unstructured":"Kang HS, Um SH, Seo YS, et al. Healthy range for serum ALT and the clinical significance of \u201cunhealthy\u201d normal ALT levels in the Korean population. J Gastroenterol Hepatol. 2011;26:292\u2013299.","journal-title":"J Gastroenterol Hepatol"},{"key":"4431_CR29","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/bmj.38050.593634.63","volume":"328","author":"HC Kim","year":"2004","unstructured":"Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ. 2004;328:983.","journal-title":"BMJ"},{"key":"4431_CR30","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cgh.2008.08.021","volume":"6","author":"EB Keeffe","year":"2008","unstructured":"Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol. 2008;6:1315\u20131341. quiz 1286.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4431_CR31","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa051285","volume":"354","author":"TT Chang","year":"2006","unstructured":"Chang TT, Gish RG, de Man R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med. 2006;354:1001\u20131010.","journal-title":"N Engl J Med"},{"key":"4431_CR32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa051287","volume":"354","author":"CL Lai","year":"2006","unstructured":"Lai CL, Shouval D, Lok AS, et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med. 2006;354:1011\u20131020.","journal-title":"N Engl J Med"},{"key":"4431_CR33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/apt.12344","volume":"38","author":"AK Singal","year":"2013","unstructured":"Singal AK, Salameh H, Kuo YF, Fontana RJ. Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B. Aliment Pharmacol Ther. 2013;38:98\u2013106.","journal-title":"Aliment Pharmacol Ther"},{"key":"4431_CR34","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/hep.27889","volume":"62","author":"DH Sinn","year":"2015","unstructured":"Sinn DH, Lee J, Goo J, et al. Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load. Hepatology. 2015;62:694\u2013701.","journal-title":"Hepatology"},{"key":"4431_CR35","first-page":"77","volume":"21","author":"G Fattovich","year":"1995","unstructured":"Fattovich G, Giustina G, Schalm SW, et al. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology. 1995;21:77\u201382.","journal-title":"Hepatology"},{"key":"4431_CR36","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/jmv.24243","volume":"87","author":"T Stroffolini","year":"2015","unstructured":"Stroffolini T, Esvan R, Biliotti E, Sagnelli E, Gaeta GB, Almasio PL. Gender differences in chronic HBsAg carriers in Italy: evidence for the independent role of male sex in severity of liver disease. J Med Virol. 2015;87:1899\u20131903.","journal-title":"J Med Virol"},{"key":"4431_CR37","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1128\/JCM.40.4.1207-1209.2002","volume":"40","author":"JH Kao","year":"2002","unstructured":"Kao JH, Chen PJ, Lai MY, Chen DS. Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbiol. 2002;40:1207\u20131209.","journal-title":"J Clin Microbiol"},{"key":"4431_CR38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jnci\/dji043","volume":"97","author":"MW Yu","year":"2005","unstructured":"Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 2005;97:265\u2013272.","journal-title":"J Natl Cancer Inst"},{"key":"4431_CR39","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1053\/jhep.2003.50098","volume":"37","author":"MF Yuen","year":"2003","unstructured":"Yuen MF, Sablon E, Yuan HJ, et al. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma. Hepatology. 2003;37:562\u2013567.","journal-title":"Hepatology"},{"key":"4431_CR40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/jhep.2003.50036","volume":"37","author":"H Sumi","year":"2003","unstructured":"Sumi H, Yokosuka O, Seki N, et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology. 2003;37:19\u201326.","journal-title":"Hepatology"},{"key":"4431_CR41","first-page":"479","volume":"61","author":"HC Kim","year":"2001","unstructured":"Kim HC, Seo GS, Kim YS, Song WG, Moon HB, Cho JH. Hepatitis B virus (HBV) genotype in korean chronic HBV carriers: whole HBV genome and it;s nucleotide sequence by single polymerization chain reaction (PCR) Method. Korean J Med. 2001;61:479\u2013488.","journal-title":"Korean J Med"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4431-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-016-4431-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4431-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T10:17:15Z","timestamp":1601288235000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-016-4431-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,29]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["4431"],"URL":"https:\/\/doi.org\/10.1007\/s10620-016-4431-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,29]]}}}